TRKA/B/C inhibitors (KinaRx)

N/A

Report date: 2025/06/11 10:21:37

NME

Base Information

Drug NameTRKA/B/C inhibitors (KinaRx)

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionNeurotrophic tyrosine kinase receptor type 3 inhibitorsNerve growth factor receptor Trk-A antagonistsNeurotrophic tyrosine kinase receptor type 2 inhibitors +[4]

TargetsNeurotrophic tyrosine kinase receptor type 3Nerve growth factor receptor Trk-ANeurotrophic tyrosine kinase receptor type 2

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKinaRx Inc

China Registration ClassN/A

Develop Information

Active CompaniesKinaRx Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A